Saudubray J, Garcia-Cazorla A
Dialogues Clin Neurosci. 2019; 20(4):301-325.
PMID: 30936770
PMC: 6436954.
Kim Y, Ko J, Song J, Lee K
Ann Lab Med. 2018; 38(6):616-618.
PMID: 30027710
PMC: 6056397.
DOI: 10.3343/alm.2018.38.6.616.
Distelmaier F, Vogel M, Spiekerkotter U, Gempel K, Klee D, Braunstein S
Pediatr Nephrol. 2007; 22(12):2119-24.
PMID: 17638024
DOI: 10.1007/s00467-007-0536-9.
Eaton S, Bartlett K, Pourfarzam M
Biochem J. 1996; 320 ( Pt 2):345-57.
PMID: 8973539
PMC: 1217938.
DOI: 10.1042/bj3200345.
Jakobs C, Sweetman L, WADMAN S, Duran M, Saudubray J, Nyhan W
Eur J Pediatr. 1984; 141(3):153-7.
PMID: 6698061
DOI: 10.1007/BF00443213.
The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.
Bohles H, Lehnert W
Eur J Pediatr. 1984; 143(1):61-3.
PMID: 6510434
DOI: 10.1007/BF00442751.
Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis.
Zerres K, Volpel M, Weiss H
Hum Genet. 1984; 68(2):104-35.
PMID: 6500563
DOI: 10.1007/BF00279301.
Seven years of experience with selective screening for organic acidurias.
Lehnert W, Niederhoff H
Eur J Pediatr. 1984; 142(3):208-10.
PMID: 6468445
DOI: 10.1007/BF00442451.
Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency).
Goodman S, Frerman F
J Inherit Metab Dis. 1984; 7 Suppl 1:33-7.
PMID: 6434842
DOI: 10.1007/BF03047371.
Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin.
Mooy P, Przyrembel H, GIESBERTS M, Scholte H, Blom W, VAN GELDEREN H
Eur J Pediatr. 1984; 143(2):92-5.
PMID: 6394338
DOI: 10.1007/BF00445792.
Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally.
Bennett M, Curnock D, Engel P, Shaw L, Gray R, Hull D
J Inherit Metab Dis. 1984; 7(2):57-61.
PMID: 6207379
DOI: 10.1007/BF01805802.
The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.
Amendt B, Rhead W
J Clin Invest. 1986; 78(1):205-13.
PMID: 3722376
PMC: 329551.
DOI: 10.1172/JCI112553.
Teratogenic inborn errors of metabolism.
Leonard J
Postgrad Med J. 1986; 62(724):125-9.
PMID: 3540927
PMC: 2418604.
DOI: 10.1136/pgmj.62.724.125.
The inborn errors of mitochondrial fatty acid oxidation.
DIVRY P, Gregersen N, Mathieu M
J Inherit Metab Dis. 1987; 10 Suppl 1:159-200.
PMID: 3119938
DOI: 10.1007/BF01812855.
Dysmorphic syndromes with demonstrable biochemical abnormalities.
Clayton P, Thompson E
J Med Genet. 1988; 25(7):463-72.
PMID: 3050094
PMC: 1050523.
DOI: 10.1136/jmg.25.7.463.
Infantile glycerol kinase deficiency--a condition requiring prompt identification. Clinical, biochemical, and morphological findings in two cases.
Kohlschutter A, Willig H, Schlamp D, Kruse K, McCabe E, Schafer H
Eur J Pediatr. 1987; 146(6):575-81.
PMID: 2828063
DOI: 10.1007/BF02467357.
3-Methylglutaconic and 3-methylglutaric aciduria in a patient with suspected 3-methylglutaconyl-CoA hydratase deficiency.
Lehnert W, Scharf J, Wendel U
Eur J Pediatr. 1985; 143(4):301-3.
PMID: 2580710
DOI: 10.1007/BF00442306.